Excitability mechanisms of neurocardiac regulation
神经心脏调节的兴奋机制
基本信息
- 批准号:8656407
- 负责人:
- 金额:$ 24.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-04-01 至 2016-03-31
- 项目状态:已结题
- 来源:
- 关键词:Action PotentialsAddressAffectAgeArrhythmiaAtrioventricular BlockAtropineAxonBaroreflexBradycardiaBrainBrain StemCarbacholCardiacCardiologyCessation of lifeComorbidityCongenital Heart DefectsDefectDiagnosisDiseaseEducational process of instructingElectrocardiogramElectroencephalographyElectrophysiology (science)EngineeringEpilepsyExhibitsFOS ProteinFOS geneFunctional disorderGene ExpressionGene MutationGeneral PopulationGeneticGoalsHeartHeart AtriumHumanImageImmediate-Early GenesImmunohistochemistryInstitutionIon ChannelJournalsK-Series Research Career ProgramsKCNA1 channelKnockout MiceLeadLeadershipLinkMapsMeasuresMediatingMedicineMentorsMethoxamineMissense MutationModelingMolecularMonitorMusMuscarinic Acetylcholine ReceptorMutant Strains MiceMutationNervous system structureNeurologyNeuronsOperative Surgical ProceduresPatientsPharmaceutical PreparationsPhasePotassium ChannelPrevalenceRecruitment ActivityRegulationResearchResearch PersonnelResearch TrainingResourcesRiskSeizuresSignal TransductionSliceStudentsTechniquesTestingTimeTissuesTrainingVagotomyVagus nerve structureVentricular ArrhythmiaWorkbasecareercareer developmentcollegeextracellularinhibitor/antagonistinterestknowledge basemeetingsmouse modelneurotransmissionnovelprematureprogramsrelating to nervous systemresponseresponsible research conductskills
项目摘要
The proposed research examines the molecular mechanisms that contribute to neurocardiac
dysfunction in mouse models of epilepsy and sudden unexplained death in epilepsy (SUDEP). People with
epilepsy are 24 times more likely than the general population to die suddenly for unexplained pathological
reasons; therefore, these deaths are classified as SUDEP. This proposal investigates the contribution of
parasympathetic neurotransmission to potentially lethal heart arrhythmias in two different epilepsy mouse
models of brain-driven cardiac dysfunction linked to SUDEP: 1) a Kcna1 potassium channel knockout mouse
model, which exhibits cardiac defects despite minimal cardiac expression; and 2) a Kcnq1 potassium channel
missense mutation mouse model, which exhibits cardiac defects associated with co-expression in brain and
heart. In Aim 1, vagotomy is used in conjunction with simultaneous video electroencephalography-
electrocardiography (EEG-ECG) to assess the effect of parasympathetic neurotransmission on cardiac
dysfunction and premature death in Kcna1-null mice. In Aim 2, Kcna1-null mice are administered drugs that
selectively activate the vagus nerve to determine whether stimulation of parasympathetic neurotransmission
increases cardiac dysfunction in Kcna1-null mice as measured by EEG-ECG. In Aim 3, vagus nerve and
intracardiac electrophysiology are used to determine if the lack of Kv1.1 channels affects vagal excitability or
vulnerability to inducible cardiac arrhythmias. In Aim 4, immunohistochemistry is used to image immediate
early gene expression to generate a map of autonomic brain centers activated by seizures in Kcna1-null mice. In
Aim 5, the same battery of tests described in Aims 1-4 for Kcna1-null mice will be used to determine if cardiac
defects in Kcnq1 mouse models of brain-heart potassium channel dysfunction have an underlying neural
contribution and show mechanistic similarities with Kcna1 models. Aims 1-4 will be completed during the K99
phase and Aim 5 during the R00 phase.
The candidate for this career development award is pursuing a career as an independent investigator in
neurocardiology, addressing research questions related to the brain-heart interaction. Of particular interest is
the genetic basis of excitability disorders, especially epilepsy, and how gene mutations can cause excitability
defects in multiple tissues at once, such as the brain and heart, providing a novel explanation for the prevalence
of disease comorbidities. For career development activities during the K99 phase, the candidate will: 1) expand
his experimental skillset; 2) increase his brain-heart knowledge-base by participating in scientific meetings;
and 3) enhance his leadership/teaching skills by mentoring students and leading seminars and journal clubs.
The candidate will also receive training in the responsible conduct of research. The candidate's institution,
Baylor College of Medicine, is well-suited for the proposed research and training goals because of the breadth
of experimental resources it offers and the number of accessible experts in neurology and cardiology.
这项拟议的研究考察了神经心脏的分子机制。
癫痫小鼠模型的功能障碍和癫痫原因不明猝死(SUDEP)。具有以下特征的人
癫痫患者因不明原因的疾病突然死亡的可能性是普通人的24倍。
原因;因此,这些死亡被归类为SUDEP。该提案调查了以下方面的贡献
两种不同癫痫小鼠对潜在致死性心律失常的副交感神经传递
与SUDEP相关的脑驱动心功能障碍模型:1)KcNA1钾通道基因敲除小鼠
模型,尽管心脏表达最少,但仍表现出心脏缺陷;2)KCNQ1钾通道
错义突变小鼠模型,表现出心脏缺陷与脑和
心。在目标1中,迷走神经切断术与同步视频脑电图术一起使用-
心电图评价副交感神经传递对心脏功能的影响
KcNA1基因缺失小鼠的功能障碍和过早死亡。在AIM 2中,KcNA1基因缺失的小鼠被给予
选择性激活迷走神经以确定刺激副交感神经传递
增加KcNA1基因缺失小鼠的心功能障碍,通过脑电-心电图测量。在目标3中,迷走神经和
心内电生理用于确定Kv1.1通道的缺乏是否影响迷走神经的兴奋性或
易诱发心律失常。在目标4中,使用免疫组织化学方法对即时图像进行成像
早期基因表达以生成KcNA1基因缺失小鼠癫痫发作激活的自主脑中心图。在……里面
AIM 5,将使用AIMS 1-4中描述的针对KcNA1基因缺失小鼠的同一组测试来确定心脏
KCNQ1小鼠脑心钾通道功能障碍模型的缺陷有神经基础
贡献,并显示出与Kcna1模型的机械相似性。目标1-4将在K99期间完成
阶段和目标5在R00阶段。
这一职业发展奖的候选人正在寻求作为一名独立调查员的职业生涯
神经心脏病学,解决与大脑-心脏相互作用相关的研究问题。特别值得关注的是
兴奋性障碍的遗传基础,特别是癫痫,以及基因突变如何引起兴奋性
多个组织同时存在缺陷,如大脑和心脏,为患病率提供了一个新的解释
疾病的合并症。对于K99阶段的职业发展活动,应聘者将:1)扩展
他的实验技能;2)通过参加科学会议,增加他的脑心知识基础;
3)通过指导学生、领导研讨会和期刊俱乐部来提高他的领导/教学技能。
候选人还将接受负责任地进行研究的培训。候选人的机构,
贝勒医学院,非常适合拟议的研究和培训目标,因为它的广度
它提供的实验资源以及可接触到的神经学和心脏病学专家的数量。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Albert E Glasscock其他文献
Albert E Glasscock的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Albert E Glasscock', 18)}}的其他基金
Biomarkers of SUDEP risk based on brain-heart-lungs network dynamics
基于脑-心-肺网络动力学的SUDEP风险生物标志物
- 批准号:
10561946 - 财政年份:2023
- 资助金额:
$ 24.4万 - 项目类别:
Neurocardiac mechanisms of epilepsy with high risk of SUDEP
SUDEP高危癫痫的神经心脏机制
- 批准号:
9898482 - 财政年份:2019
- 资助金额:
$ 24.4万 - 项目类别:
Neurocardiac mechanisms of epilepsy with high risk of SUDEP
SUDEP高危癫痫的神经心脏机制
- 批准号:
10019197 - 财政年份:2019
- 资助金额:
$ 24.4万 - 项目类别:
Respiratory mechanisms of epilepsy with high risk of SUDEP
SUDEP高危癫痫的呼吸机制
- 批准号:
10019170 - 财政年份:2019
- 资助金额:
$ 24.4万 - 项目类别:
Complex genetic interactions in mouse model of sudden death in epilepsy (SUDEP)
癫痫猝死小鼠模型(SUDEP)中复杂的遗传相互作用
- 批准号:
8765025 - 财政年份:2014
- 资助金额:
$ 24.4万 - 项目类别:
Complex genetic interactions in mouse model of sudden death in epilepsy (SUDEP)
癫痫猝死小鼠模型 (SUDEP) 中复杂的遗传相互作用
- 批准号:
8841421 - 财政年份:2014
- 资助金额:
$ 24.4万 - 项目类别:
Excitability mechanisms of neurocardiac regulation
神经心脏调节的兴奋机制
- 批准号:
8609178 - 财政年份:2011
- 资助金额:
$ 24.4万 - 项目类别:
Excitability mechanisms of neurocardiac regulation
神经心脏调节的兴奋机制
- 批准号:
8833324 - 财政年份:2011
- 资助金额:
$ 24.4万 - 项目类别:
Excitability mechanisms of neurocardiac regulation
神经心脏调节的兴奋机制
- 批准号:
8247703 - 财政年份:2011
- 资助金额:
$ 24.4万 - 项目类别:
Excitability mechanisms of neurocardiac regulation
神经心脏调节的兴奋机制
- 批准号:
8088922 - 财政年份:2011
- 资助金额:
$ 24.4万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 24.4万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 24.4万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 24.4万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 24.4万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 24.4万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 24.4万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 24.4万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 24.4万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 24.4万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 24.4万 - 项目类别:
Research Grant














{{item.name}}会员




